Treat-to-target urate-lowering therapy (ULT) is considered best practice in gout management, yet its impact on health-related quality of life (HRQoL) remains unclear. A post-hoc analysis of a randomized, multicenter trial by Austin Barry, MD, and…
Treat-to-target urate-lowering therapy (ULT) is considered best practice in gout management, yet its impact on health-related quality of life (HRQoL) remains unclear. A post-hoc analysis of a randomized, multicenter trial by Austin Barry, MD, and…